Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
NCT04849559 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2024-04-16
Summary
To evaluate the effects of tradipitant relative to placebo on satiation, gastric volume, gastric accommodation, and gastric emptying in healthy volunteers.
Conditions
- Healthy Volunteer
Interventions
- DRUG
-
Tradipitant Capsule
- DRUG
-
Placebo Capsule
Sponsors & Collaborators
- collaborator OTHER
- lead INDUSTRY
Principal Investigators
-
Vanda Pharmaceuticals · Vanda Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2021-09-24
- Completion
- 2021-09-24
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers
NCT01267071 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults
NCT03718390 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
NCT03565861 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
NCT04183686 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic Function
NCT03799848 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients
NCT03070509 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan in Healthy Volunteers
NCT04156646 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers
NCT02259842 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Bioactive Peptides' Effect on Digestive Discomfort Symptoms of the Elderly
NCT04450979 ·Status: COMPLETED ·Phase: NA
-
Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat
NCT04299633 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
NCT02770404 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants
NCT06887010 ·Status: COMPLETED ·Phase: PHASE1
-
Gut Transit Effect on Enterohepatic Circulation
NCT03501498 ·Status: COMPLETED ·Phase: NA
-
Safety of Larazotide Acetate in Healthy Volunteers
NCT00386490 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants
NCT07063342 ·Status: RECRUITING ·Phase: PHASE1
-
A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function
NCT06938529 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NST-6179 in Healthy Subjects
NCT05181085 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects
NCT02225626 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248
NCT04617509 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2
NCT03802526 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949
NCT02099071 ·Status: COMPLETED ·Phase: PHASE1
-
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
NCT01848340 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers
NCT01080820 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to Immediate-release Nicotinic Acid and Placebo in Healthy Subjects and Subjects With Prediabetes
NCT06378125 ·Status: COMPLETED ·Phase: PHASE1
-
An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.
NCT05765981 ·Status: RECRUITING ·Phase: EARLY_PHASE1